Hospira Announces Positive Results From Phase I U.S. Clinical Trial of ... - MarketWatch (press release) PDF Print
MarketWatch (press release)
Erythropoietin is a treatment for anemia associated with chronic renal failure and chemotherapy. The controlled, randomized trial of 100 patients on hemodialysis who had already been treated with Epogen took place at 20 different hemodialysis centers

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.